Previous 10 | Next 10 |
2023-08-24 00:26:38 ET Summary Labrador Iron Ore Royalty Corporation has a royalty on a mine that can produce iron ore for carbon-free steelmaking, while Deterra Royalties has a royalty on a lower-grade mine that cannot. LIORC trades at a cheap price-to-earnings ratio with plenty ...
NEW YORK, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that the US Food and Drug Administration (FDA) has provided a complete response to its Biologics License Application (BLA...
NEW YORK, July 30, 2023 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an activity report for the fourth quarter ended June 30, 2023. Activities Report Cash balance at the end o...
2023-07-14 03:17:31 ET Summary Mesabi Trust, a New York-based royal trust involved in the Minnesota iron ore mining business, has been given a "Hold" recommendation due to uncertainty surrounding the business outlook. The trust's royalty income has been negatively impacted by Clev...
NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, is pleased to announce that it has appointed Dr. Philip R. Krause, a member of the Board of Directors, to a formal strategic advisory rol...
2023-05-31 13:45:43 ET Gainers: Aemetis ( AMTX ) +10% . Centerra Gold ( CGAU ) +9% . Mesabi Trust ( MSB ) +7% . Perpetua Resources ( PPTA ) +7% . Dakota Gold ( DC ) +6% . Losers: Ero Copper ( ERO ) -10% . Benson Hill ( BHIL )...
NEW YORK, May 25, 2023 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today reported operational highlights and financial results for the period ended March 31, 2023. OPERATIONAL HIGHLIGHTS Re...
2023-04-27 13:15:02 ET Summary Mesabi Trust's stock dropped after the Cleveland-Cliffs Inc. CEO announced Northshore Mining would serve as a "swing operation." Mesabi cancelled April distributions due to uncertainties surrounding those Cleveland-Cliffs plans. Recent reports su...
2023-04-26 07:27:38 ET Mesabi Trust ( NYSE: MSB ) closed -12.9% in Tuesday's trading after Cleveland-Cliffs ( NYSE: CLF ) CEO Lourenco Goncalves said Northshore Mining would continue to serve as a " swing operation ," meaning Northshore would be used "as needed." ...
NEW YORK, April 25, 2023 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced it has completed a global private placement primarily to Mesoblast’s existing major US, UK, and Australian shareh...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, July 21, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, announced today that the confirmatory Phase 3 trial of its allogeneic, immunoselected, and industrially manufactured stromal cell product...
2024-07-13 04:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
NEW YORK, July 08, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, announced today it has resubmitted its BLA for approval of Ryoncil ® (remestemcel-L) in the treatment of children with SR-aGVHD....